Immediate Impact

1 from Science/Nature 66 standout
Sub-graph 1 of 22

Citing Papers

Inflammatory response of nanoparticles: Mechanisms, consequences, and strategies for mitigation
2024 Standout
Long COVID science, research and policy
2024 Standout
2 intermediate papers

Works of Kévin Bigaut being referenced

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
2020
Ocrelizumab for the treatment of multiple sclerosis
2018

Author Peers

Author Last Decade Papers Cites
Kévin Bigaut 365 370 115 330 27 649
Olivier Heinzlef 365 200 106 199 23 573
Shitiz Sriwastava 174 460 75 247 57 680
Saurabh Kataria 83 311 46 209 48 523
Finja Schweitzer 106 308 53 149 27 543
Yael Stern 512 252 54 165 15 657
O. Heinzlef 299 228 54 63 18 514
Owen Pearson 498 178 188 39 28 679
Sara Salama 438 458 30 97 20 616
Susana Otero‐Romero 550 276 113 54 26 700
Steffen Leiz 127 142 43 71 24 566

All Works

Loading papers...

Rankless by CCL
2026